Boston Common Asset Management LLC Boosts Position in Colgate-Palmolive Company (CL)
Boston Common Asset Management LLC boosted its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 20.7% during the first quarter, Holdings Channel reports. The institutional investor owned 67,745 shares of the company’s stock after buying an additional 11,630 shares during the period. Boston Common Asset Management LLC’s holdings in Colgate-Palmolive were worth $4,958,000 as of its most recent filing with the SEC.
Other large investors have also recently bought and sold shares of the company. Alpha Windward LLC raised its stake in Colgate-Palmolive by 0.6% in the first quarter. Alpha Windward LLC now owns 2,829 shares of the company’s stock valued at $207,000 after buying an additional 18 shares in the last quarter. Weybosset Research & Management LLC raised its stake in Colgate-Palmolive by 1.9% in the first quarter. Weybosset Research & Management LLC now owns 67,493 shares of the company’s stock valued at $4,940,000 after buying an additional 1,270 shares in the last quarter. ELM Advisors LLC raised its stake in Colgate-Palmolive by 1.0% in the first quarter. ELM Advisors LLC now owns 4,445 shares of the company’s stock valued at $325,000 after buying an additional 45 shares in the last quarter. Honkamp Krueger Financial Services Inc. raised its stake in Colgate-Palmolive by 0.3% in the first quarter. Honkamp Krueger Financial Services Inc. now owns 19,317 shares of the company’s stock valued at $1,414,000 after buying an additional 57 shares in the last quarter. Finally, TNB Financial purchased a new stake in Colgate-Palmolive during the first quarter valued at about $927,000. 73.69% of the stock is currently owned by institutional investors and hedge funds.
Colgate-Palmolive Company (NYSE CL) traded up 0.34% on Tuesday, hitting $71.69. The stock had a trading volume of 771,068 shares. The firm has a market cap of $63.15 billion, a P/E ratio of 26.64 and a beta of 0.80. Colgate-Palmolive Company has a 1-year low of $63.43 and a 1-year high of $77.27. The firm’s 50-day moving average price is $72.71 and its 200-day moving average price is $72.83.
Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, July 21st. The company reported $0.72 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.72. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. The firm had revenue of $3.83 billion during the quarter, compared to the consensus estimate of $3.89 billion. During the same quarter in the previous year, the company posted $0.70 EPS. The business’s revenue for the quarter was down .5% compared to the same quarter last year. On average, equities research analysts predict that Colgate-Palmolive Company will post $2.89 earnings per share for the current year.
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, August 15th. Shareholders of record on Tuesday, July 18th will be given a $0.40 dividend. The ex-dividend date is Friday, July 14th. This represents a $1.60 annualized dividend and a yield of 2.24%. Colgate-Palmolive’s payout ratio is 59.48%.
Several research firms recently issued reports on CL. Bank of America Corporation upped their price target on Colgate-Palmolive from $78.00 to $80.00 and gave the company a “buy” rating in a research report on Wednesday, May 31st. BidaskClub downgraded Colgate-Palmolive from a “hold” rating to a “sell” rating in a research note on Saturday, June 24th. Vetr downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and set a $76.67 price objective for the company. in a research note on Wednesday, May 17th. Royal Bank Of Canada restated a “hold” rating and set a $74.00 price objective on shares of Colgate-Palmolive in a research note on Thursday, May 25th. Finally, Jefferies Group LLC began coverage on Colgate-Palmolive in a research note on Tuesday, April 18th. They set a “hold” rating and a $78.00 price objective for the company. Two research analysts have rated the stock with a sell rating, twelve have given a hold rating and two have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $75.82.
In other Colgate-Palmolive news, CFO Dennis J. Hickey sold 73,872 shares of Colgate-Palmolive stock in a transaction on Thursday, August 3rd. The stock was sold at an average price of $71.80, for a total value of $5,304,009.60. Following the completion of the transaction, the chief financial officer now owns 484,985 shares in the company, valued at approximately $34,821,923. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Patricia Verduin sold 3,833 shares of Colgate-Palmolive stock in a transaction on Thursday, June 15th. The shares were sold at an average price of $75.67, for a total value of $290,043.11. Following the completion of the transaction, the insider now owns 53,022 shares of the company’s stock, valued at approximately $4,012,174.74. The disclosure for this sale can be found here. In the last quarter, insiders sold 217,969 shares of company stock valued at $15,710,108. Corporate insiders own 1.02% of the company’s stock.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with Analyst Ratings Network's FREE daily email newsletter.